SUMMARY
INTRODUCTION
Understanding the differentiation of memory T cells is key to the rational design of effective and innovative strategies for developing better vaccines. Induction of long-lived memory CD8 + T cells that can mediate protective immune responses against microbial infections is largely programmed during the initial priming and requires three distinct signals, namely cognate antigen, costimulation, and inflammation. Although understanding the fine mechanisms of these processes is paramount to the design of better vaccination strategies, the cues that govern memory cell reactivation are poorly defined. Both cognate antigen recognition and inflammation were demonstrated to promote the activation of pathogen-specific memory CD8 + T cells. Earlier reports focusing on memory CD8 + T cells either in nonimmunized or immunized hosts documented that, similarly to natural killer (NK) cells (Chaix et al., 2008; Lucas et al., 2007; Nguyen et al., 2002) , memory CD8 + T cells can respond to distinct inflammatory cytokines (Berg et al., 2003; Kambayashi et al., 2003; Kohlmeier et al., 2010; Liu et al., 2002; Yajima et al., 2005; Zhang et al., 1998) . Upon incubation with a combination of interleukin (IL)-12 and IL-18, memory CD8 + T cells can produce interferon gamma (IFN-g) (Berg et al., 2003; Kambayashi et al., 2003) ; IL-15 is able to trigger their activation by mimicking T cell receptor (TCR) crosslinking (Liu et al., 2002; Yajima et al., 2005; Zhang et al., 1998) , and type I IFN (IFN I) directly enhances cytolytic activity of virus-specific memory CD8 + T cells (Kohlmeier et al., 2010) . So far however, it is unclear whether, in comparison to cognate antigen-driven reactivation, such interleukin-driven mechanisms are critical and represent an important component of vaccine-induced memory CD8 + T cell reactivation in vivo. In fact, a recent report supported a strong role for inflammation in optimal reactivation of immunization-induced memory CD8 + T cells in vivo (Wirth et al., 2011) .
Adding to this body of literature was the suggestion that dendritic cells (DCs) play a key role in promoting robust memory CD8 + T cell proliferation during a recall infection (Zammit et al., 2005) . However, the precise identity of the relevant cell(s) and the mechanisms through which they act, e.g., promoting inflammation and more precisely which signals, presenting T cell cognate antigens or both, still remained unclear. Other myeloid-derived cells such as monocytes, macrophages, and neutrophils express major histocompatibility complex (MHC) class I molecules and are also equipped with sets of pattern recognition receptors that efficiently sense pathogens-derived molecules, leading to the secretion of multiple inflammatory mediators (Iwasaki and Medzhitov, 2010) . Therefore, establishing the contribution of antigen-dependent and independent signals to memory CD8 + T cell activation and the cell types orchestrating this process is a still unanswered question of considerable interest to unravel memory CD8 + T cell function and protective efficacy in vivo. Using mice immunized with the intracellular bacterium Listeria monocytogenes (Lm), which develop long-lived protective CD8
+ T cell memory, we had established that control of Lm growth during recall infection occurs within a few hours (Narni-Mancinelli et al., 2011) . Consistent with others (Berg et al., 2003; Iwai et al., 2008; Kambayashi et al., 2003) , we found that vaccine (Lm)-induced memory CD8 + T cells produced IFN-g independently of cognate antigen recognition (Bajé noff et al., 2010) , suggesting that initial activation of memory CD8 + T cells is regulated by other mechanisms. In the current study, we took advantage of the Lm immunization model to investigate the mechanisms of memory CD8 + T cell activation in vivo. We establish that pathogen-specific memory CD8 + T cells undergo initial reactivation inside tissues by expressing strong effector functions and activation markers without cognate antigen recognition requirements. Most importantly, we found that reactivation is mostly orchestrated by a subset of myeloid cells, the Ly6C + CCR2 + inflammatory monocytes, which provide inflammatory signals to memory cells upon triggering of ''danger'' pathways (IFN-I, inflammasome) by molecules derived from several classes of microbial pathogens. These findings describe a unique role for inflammatory monocytes and provide a thorough understanding of the mechanisms that control the reactivation of memory CD8 + T cells induced upon immunizations.
RESULTS

Cognate Antigen Recognition Is Not Required for Early Activation of Memory CD8 + T Cells In Vivo
We first investigated whether antigen is required for the early activation of memory CD8 + T cells induced after a strong immunization. We grafted wild-type (WT) C57BL/6 (B6) mice with physiological numbers of naive CD8 + T cells expressing (1) the monoclonal T cell receptor (TCR) OT-I specific for the model antigen Ovalbumin (Ova) and (2) a traceable fluorescent protein (green fluorescent protein [GFP] or Tomato). We subsequently immunized recipient animals with WT Lm-expressing Ova (Lm-Ova), which induced OT-I cells to differentiate into memory cells. Five weeks after primary immunization (and up to 3 months, not shown), mice were challenged with WT Lm either expressing or not the Ova antigen. The functional and cell-surface phenotypes of splenic OT-I memory cells were then analyzed ex vivo without further restimulation ( Figures 1A-1C ). Control mice received naive OT-I GFP + cells. As early as 8 hr after infection and sustained over 48 hr, OT-I memory cells, but not naive cells, expressed major effector molecules such as IFN-g, granzyme B (GrB), and perforin ( Figures 1A and 1B) . Concomitant upregulation of cell-surface markers reflecting T cell activation and trafficking (CD69, CCR5), adhesion and costimulatory molecules (CD11a, NKG2D), and effector differentiation (CD25 [Kalia et al., 2010; Pipkin et al., 2010] ) were also observed ( Figure 1B and not shown). Increased expression of T-bet and Eomesodermin, two major transcriptional master regulators of T cell differentiation into IFN-g and cytolytic effectors (Intlekofer et al., 2005) , confirmed that memory cells from challenged mice underwent a strong program of differentiation ( Figure 1C ). The kinetics and extent of modulation of all functional markers -in terms of proportion, absolute numbers (not shown) of memory cells, and amounts of expression (mean fluorescence intensity [MFI] )-were equivalent whether cognate antigen was present or not, and even upon challenge with low numbers of bacteria (Figures S1A-S1C available online). Nevertheless, antigen was required for T cell proliferation ( Figure S1D ). Of note, naive OT-I cells showed no signs of activation without antigen ( Figures  1B and 1C and GrB ($45%) and upregulated activation markers (CD69, CD25, not shown), therefore extending these results to memory CD8 + T cells induced by acute viral infection. It is also noticeable that the proportion of memory and NK cells undergoing IFN-g and GrB expression was equivalent ( Figure S2D ). Importantly and in line with these observations, naive recipient mice Triggering of Inflammasome and IFN-I Pathways Promote Memory CD8 + T Cell Differentiation into
Effectors
We next investigated the molecular mechanisms regulating the activation of memory CD8 + T cells. Given that activation was observed across infections with various microbial pathogens, we hypothesized that common cytokine signals are likely to control these processes. In line with others studies (Berg et al., 2003; Kambayashi et al., 2003; Kohlmeier et al., 2010; Liu et al., 2002; Yajima et al., 2005; Zhang et al., 1998) induced their secretion of IFN-g, whereas incubation with IL-15 or IFN-I led to their expression of GrB, consistent with the idea that a combination of these cytokines is required for IFN-g and GrB expression in vivo. Secretion of these mediators involves nonoverlapping ''danger'' pathways; production of bioactive IL-18 from its pro-IL-18 precursor requires inflammasomecaspase-1 proteolytic cleavage (Kuida et al., 1995) , whereas the trans-presentation of IL-15 (Burkett et al., 2004) upon IFN-I stimulation requires IRF3 and IRF7 transcription factors (Beuneu et al., 2011; Lucas et al., 2007 
Ly6C
+ monocytes ( Figure 4A ), was inhibited by $80%. Thus, Ly6C + monocytes most likely promoted IFN-g-secretion from the memory cells through inflammasome-mediated release of IL-18. Next, we monitored the cell-surface expression of IL-15Ra by various myeloid splenic cell subsets that could trans-present bioactive IL-15 (Sandau et al., 2004) . Ly6C Figure S4A ) upregulated this receptor at far superior amounts than cDCs, macrophages or neutrophils (Figures 4C and S4B) . Strong upregulation of IL-15Ra was true not only in mice infected with Lm, but also with MCMV, S. pneumoniae, and P. berghei and upon poly(I:C) injection ( Figure 4D) . Therefore, in all organs targeted by the different microbes and in which Ly6C + monocytes are rapidly recruited (Shi and Pamer, 2011) , these cells exhibited a functional advantage in expressing high cell-surface bioactive IL-15Ra-IL-15 complexes over other myeloid cell types.
Inflammatory Monocytes Efficiently Respond to IFN-I and trans-Present Bioactive IL-15
We further characterized the origin and fate of activated Ly6C + monocytes. For this, we took advantage of a genetically engineered mouse model that express the CFP fluorescent reporter protein fused to the diphtheria toxin receptor (DTR) under the control of the CCR2 promoter (CCR2-DTR-CFP + [Hohl et al., 2009] ). In these mice, Ly6C + monocytes, which also represent the major CCR2 + cell subset in vivo (Geissmann et al., 2003; Serbina et al., 2003) , could not only be traced (CFP + ) but also selectively eliminated (DTR + ) upon diphtheria toxin (DT) injection ( Figure S4C ). In line with current knowledge (Geissmann et al., 2010) Figure 5A ). Although CFP + cells remain phenotypically distinct from all of the previous cell populations in mice challenged with Lm or MCMV, they upregulated cell-surface markers that define other myeloid cell types such as CD11c (DC), F4/80 (macrophages), and pDCs (PDCA-1), suggesting that they may differentiate into functional DCs and/or macrophages during microbial-driven activation. In support of this hypothesis, activated CCR2 + Ly6C + monocytes upregulated cell-surface expression of MHC-II molecules, CD40 and CD86 costimulatory molecules, the C-type lectin CD209b, and Sca-1 (that marks IFN-I signaling [Essers et al., 2009] ), as well as IL-15Ra in the course of the various infections ( Figures 5A, 5B, S4C , and S4D).
Results in Figure 3B suggested that IFN-I signaling acts by enhancing IL-15 trans-presentation. In line with this hypothesis, Ly6C + monocytes responded to recombinant IFN-I in vivo and induced downstream phosphorylation of STAT1, greater than in cDCs or neutrophils (factor of 1.5-3 (MFI), Figure S5 ). We next investigated whether expression of IL-15Ra on activated Ly6C + monocytes required IFN-I signaling within the monocytes.
For this, we generated mixed chimera mice reconstituted with bone marrow cells from IFN-I receptor-deficient (Ifnar1
) and WT CD45.1 + mice and monitored IL-15Ra expression after WT Lm infection ( Figure 5C ). Upregulation was severely impaired consistent with our previous observations. In support of this hypothesis, we also found that the transient clusters of OT-I memory cells-some of which were IFN-g + -that we previously described in the red pulp area of infected spleens by 6-12 hr after challenge infection (Bajé noff et al., 2010) also contained massive numbers of interacting CCR2 + inflammatory monocytes ( Figure 6B ). This was not observed in unchallenged mice containing resting OT-I memory cells.
By 24 hr, the proportion and numbers (not shown) of IFN-g + OT-I (6.9%) and endogenous (non-OT-I) memory cells in CCR2-DTR-depleted mice were equivalent to those of unchallenged mice (0.2%) and significantly reduced in comparison to non-DT treated mice (60.8%; Figures 6A and 6C ). At this time, endogenous GrB + memory CD8 + T cells (12.4%) were also significantly diminished and at equivalent proportions (5.8%) to that of unchallenged mice (4%; Figure 6C ). However, the frequencies of OT-I memory cells expressing GrB was comparable in both experimental groups, suggesting that other cell types such as cDCs or macrophages (Lucas et al., 2007; Mortier et al., 2009 ) could compensate for the loss of Ly6C + monocytes
and trans-present sufficient levels of bioactive IL-15 to OT-I memory cells ( Figure 6A ). Because activation of NK cells depends on IFN-I, IL-15, and IL-18 cytokines (Beuneu et al., 2011; Chaix et al., 2008; Lucas et al., 2007) , we reasoned that inflammatory monocytes also regulated NK cell activation. As hypothesized, the proportion of IFN-g + and GrB + NK cells decreased substantially in DT-treated CCR2-DTR mice challenged with WT Lm respectively at 8 and 24 hr and was close to that of unchallenged mice ( Figure 6D Figures 6A and 6D ), we hypothesized that other myeloid cell types must be involved. Several reports using the CD11c-DTR transgenic mouse model, in which the DTR is expressed under the CD11c promoter, allowing for selective depletion of CD11c + cells (Jung et al., 2002) , suggested that cDCs orchestrate the activation of NK and memory CD8 Figure S6 ). GrB was still upregulated on the distinct lymphocytes from DT-treated DTRexpressing animals and was equivalent to that of nondepleted animals. Analysis of the populations eliminated upon DT injection in WT Lm infected and uninfected DTR-expressing mice revealed that in CD11c-DTR mice, cDCs (CD11c hi CD8a + and CD8a À subsets) and splenic macrophages (F4/80 + CD11b + ) were efficiently eliminated (80% and 96% respectively) whereas in CCR2-DTR mice, depletion mostly targeted Ly6C + monocytes (>95%) ( Figure S7 and not shown). This suggested that inflammatory monocytes or cDCs and subsets of splenic macrophages compensated for each other's respective loss and provided a sufficient amount of trans-presented IL-15 to lymphocytes.
To assess this hypothesis further, we used clodronate liposomes, a well-established nongenetic method that eliminates a wide array of phagocytic cells (Chow et al., 2011) . Clodronate liposome injection depleted Ly6C + monocytes (by $90%) and splenic macrophages (by $80%), as well as cDCs (by $50%) and neutrophils ($20%) ( Figure S7 ). However, myeloid cells exhibiting high turnover, such as monocytes or neutrophils, underwent rapid replacement and fully restored their homeostasis by 5-7 days (van Rooijen et al., 1989 and Figure S7 ). We injected WT and CCR2-DTR B6 mice with clodronate or PBS control liposomes 1 or 6 days prior to transfer of purified OT-I memory cells, DT treatment and infection with WT Lm ( Figures   7A and S7 ). Twenty-four hrs post-challenge infection, upregulation of GrB expression and secretion of IFN-g by OT-I memory CD8 + T cells was fully abrogated in day 1-clodronate liposome-depleted mice compared to untreated control mice (GrB:28 versus 63%; IFN-g: 4 versus 55%) both in frequencies and numbers ( Figure 7A and not shown). Likewise, upregulation of GrB and secretion of IFN-g by NK cells was prevented ( Figure 7B ). Thus, as hypothesized, eliminating these subsets of phagocytic cells efficiently abrogated the upregulation of GrB by memory CD8 + T and NK cells, suggesting that they are required for sustained expression of bioactive IL-15 (Lucas et al., 2007; Mortier et al., 2009) . In WT and CCR2-DTR mice treated with clodronate liposomes 6 days prior, in which Ly6C + monocytes and neutrophils levels were largely restored but splenic macrophages were still absent and the proportion of cDC stayed comparable to day 1-treated mice ( Figure S7 ), Figure 7C ). The proportion of IFN-g + memory CD8 + T (OT-I:81.3%, endogenous, not shown) and NK (63.5%) cells was significantly decreased in DT-treated animals (OT-I:49.2% and NK:31.8%), demonstrating that also in the case of a viral infection, inflammatory monocytes exhibited a critical role in activating these lymphocytes. Thus, these cells are important master regulators of memory CD8 + and NK lymphocytes activation in vivo. We next assessed whether inflammatory monocytes modulated the early activation of cognate antigen-specific memory CD8 + T cell-responses. For this, CCR2-DTR mice either expressing or not the MHC-I K d molecule were transferred with WP20 memory cells, treated or not treated with DT, and challenged with WT Lm ( Figure 7D ). Twenty-four hrs later, the frequency of WP20 memory cells secreting IFN-g was significantly lower in DT-treated compared to untreated mice whether cognate antigen was presented or not. Therefore, Lm-specific memory CD8 + T cells underwent comparable differentiation into effector cells with or without cognate antigen stimulation and this process was largely controlled by Ly6C + monocytes. Thus, Ly6C + monocyte-derived inflammatory signals IL-18 and IL-15 drive the early phases of memory CD8 + T cell activation. Finally, to assess whether Ly6C + monocytes also regulated cognate antigen-specific memory CD8 + T cell-responses, we measured OT-I memory cell proliferation in CCR2-DTR mice treated or not treated with DT 3 days after challenge infection with DActA Lm-Ova, a highly attenuated strain of Lm ( Figure 7E ). We used DActA Lm-Ova instead of WT Lm-Ova to prevent the uncontrolled bacterial growth that occurs in Ly6C + monocytedepleted mice (Shi and Pamer, 2011) . We observed a significant loss of proliferation (factor of >2), suggesting that beyond their effect on early T cell differentiation into effector cells, inflammatory monocytes also impacted subsequent cognate antigendependent proliferative responses, reinforcing their important role during CD8 + T cell memory responses.
DISCUSSION
This study demonstrates that Ly6C + CCR2 + inflammatory monocytes are critical mediators of memory CD8 + T and NK lymphocyte activation in vivo. Upon detection of microbial pathogen-derived ''danger signals'' through triggering of type I interferon and inflammasome activation pathways, these cells directly provide important inflammatory cytokines-e.g., IL-18, IL-15, and possibly IFN-I-that directly mediate the activation of immunization-induced memory CD8 + T and NK lymphocytes. ). This promotes a protective Th1 cell-type environment through the rapid release of high levels of IFN-g that participate in the innate immune defense of the host. Our results also uncouple the pathways that orchestrate the differentiation of memory and NK cells into IFN-g + versus GrB + effector cells.
We highlight a unique function of inflammatory monocytes as main providers of bioactive IL-18 and IL-15 that promote rapid memory CD8 + T cell activation in vivo. Other cell types have been shown to produce these cytokines in vitro and in vivo (Lucas et al., 2007; Mortier et al., 2009; Mortier et al., 2008) . Cells from the macrophage phagocyte system, DCs, and neutrophils express specialized innate immune receptors, allowing for early detection of potential danger signals (Iwasaki and Medzhitov, 2010) . A recent study suggested that cDCs, via NLRC4 inflammasome activation triggered by distinct microbial infections, can regulate noncognate IFN-g secretory activity of pathogenspecific memory CD8 + T cells through an IL-18-IL-18R-dependent mechanism (Kupz et al., 2012) . Although both sets of data suggest a comparable inflammasome-IL-18-dependent molecular mechanism to control memory CD8 + T cell differentiation into IFN-g-secreting effector cells, our results favor an essential role for inflammatory monocytes and possibly splenic macrophages rather than cDCs. This could be explained by differences in the experimental systems that have been used, particularly given that the CD11c-DTR-expressing mouse not only induces elimination of cDCs (Jung et al., 2002) , but also of subsets of splenic macrophages including F4/80 + macrophages and probably other resident macrophages from the spleen (Chow et al., 2011; Probst et al., 2005) . In the CCR2-DTR mouse, Ly6C + monocytes, which represent the major immune cell expressing CCR2, underwent $95% elimination upon DT injection while other splenic myeloid cell populations were largely preserved (Hohl et al., 2009) . With the combined use of the CD169-DTR mouse model that eliminates CD169 + Moma-1 + marginal metallophilic macrophages (MMMs) and ER-TR9 + marginal zone macrophages (MZMs) and in which we observed 50% less of Ly6C + monocytes (our unpublished data), but not F4/80 + redpulp macrophages or cDCs (Miyake et al., 2007) , our data suggest that neither MMM nor MZM tissue-resident macrophages are likely to have a major contribution in memory CD8 + T and NK cell activation. Thus, distinct genetic and nongenetic loss of function experiments in vivo, in vitro activation assays of memory CD8 + T cells, and visualization of in situ interactions between Ly6C + monocytes and memory CD8 + T cells altogether provide strong support to inflammatory monocytes rather than cDCs as most critical players of IL-18-driven IFN-g-secretion by pathogen-specific memory CD8 + T cells. Another possible explanation for the discrepancy with our study may be that impaired noncognate T cell activation is subsequent to the loss Immunity Monocyte-Derived Cytokines Activate Lymphocytes of cDCs that were shown to be critical for recovering and shuttling blood-inoculated bacteria in the spleen (Edelson et al., 2011; Neuenhahn et al., 2006) .
Although cDCs and macrophages can trans-present IL-15 to CD8 + T cells, they exhibit distinct functional roles: IL-15 derived from cDCs contributes to central memory cell maintenance, whereas that from macrophages supports vaccine-induced effector CD8 + T cell transition to the memory stage (Mortier et al., 2009 ). Likewise, DC-derived IL-15 is a critical mediator of inflammatory responses in vivo (Ohteki et al., 2006) and prime NK cells (Lucas et al., 2007; Mortier et al., 2008 (Mortier et al., 2009) . Indeed, inflammatory monocytes form important clusters with memory CD8 + T cells after the challenge infection in splenic red pulp, in which they probably provide bioactive IL-15, but also interact with F4/80 + macrophages mostly found in the red pulp, supporting the idea that both cell subsets contribute to IL-15-dependent activation and reflecting the spatio-temporal specialization of IL-15 trans-presentation in vivo (Mortier et al., 2009) . A previous study suggested an essential role for cDCs in optimal cognate-antigen driven memory CD8 + T cell-responses against Lm, vesicular stomatitis, and influenza viruses during the first 24-48 hr after challenge infection (Zammit et al., 2005) . We found that inflammatory monocytes provided essential stimuli promoting robust Lm-specific memory CD8 + T cell-proliferative responses. In this study too, the apparent discrepancy with our data may result from the CD11c-DTR genetic conditional depletion system that was used (Chow et al., 2011; Jung et al., 2002; Probst et al., 2005) . With regards to cognate antigen-driven memory CD8 + T cell responses, both our results and this report show an impact on effective memory CD8 + T cell proliferation.
We found that whereas inflammatory cytokines, but not T cell cognate antigens, are essential to initiate memory CD8 + T cell reactivation, the expansion of memory cells requires the presence of cognate antigen, which may be presented by cDCs and/or inflammatory monocytes upon differentiation into potent antigen-presenting cells (Shi and Pamer, 2011) . Indeed, one possible model is that inflammatory monocytes provide inflammatory stimuli while cDCs present cognate T cell antigens.
The cytokines that rapidly lead to efficient mobilization of memory CD8 + T and NK lymphocytes are released upon triggering of pathways that require the recognition of ''danger'' molecules by specialized sets of innate immune receptors (Iwasaki and Medzhitov, 2010) . These innate sensors represent a very first line of alert of the immune system that is switched on only in potentially harmful situations. These pathways are stimulated by almost every microbial pathogen and must have coevolved with the host immune defenses; they involve the recognition by the host immune system of highly conserved pathogen-derived molecules such as DNA and pore-forming toxins like listeriolysin O, hemozoin, pneumolysin, and ESAT-6 (Dostert et al., 2009; Hara et al., 2008; Shoma et al., 2008) . Monocytes and their functional progeny, which represent immune cells of high motility and astonishing plasticity, are equipped to detect and provide high levels of these inflammatory mediators. Importantly, this mechanism also provides a Th1 cell-type (IFN-g-dependent) protective environment (Berg et al., 2003; Kambayashi et al., 2003) while cognate antigen-specific responses take place. The release of substantial amounts of IFN-g promotes expression of antimicrobial functions by effector cells such as macrophages and monocytes (Barton et al., 2007) , which not only contribute to early pathogen destruction but also to the priming, polarization, and proliferation of Th1 cell-type T cells (Das et al., 2001 ). Cognate antigen recognition by noncognate antigen-activated memory CD8 + T cells in vivo leads to significantly stronger IFN-g response by these T cells (factor of $3, not shown). Upregulation of cytolytic markers by memory cells makes them ready to kill cells that present their cognate antigen. Similarly, expression of the CD25 marks their differentiation into potent effector cells (Kalia et al., 2010; Pipkin et al., 2010) and is required for their proliferation, which only occurs upon actual recognition of their cognate antigen.
In summary, we describe a general mechanism of lymphocyte activation optimized through the lack of requirement for antigen specificity, yet controlled via tight cellular compartmentalization of IL-15 and IL-18 signals. These findings may open novel therapeutic perspectives in which targeted stimulation of Ly6C + monocytes or its human equivalent to selectively provide bioactive IL-18 and IL-15 could boost the efficacy of antimicrobial and antitumoral protective immune responses.
EXPERIMENTAL PROCEDURES Mice
All mice were housed and bred in our SPF animal facility; detailed description is provided in the Supplemental Information. 
